Literature DB >> 9350941

Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot.

D A Harrison1, L Harris, S C Siu, C J MacLoghlin, M S Connelly, G D Webb, E Downar, P R McLaughlin, W G Williams.   

Abstract

OBJECTIVES: We sought to determine the features associated with sustained monoform ventricular tachycardia (VT) in adult patients late after repair of tetralogy of Fallot (TOF) and to review their management.
BACKGROUND: Patients with repair of TOF are at risk for sudden death. Risk factors for ventricular arrhythmia have been identified from patients with ventricular ectopic beats because of the low prevalence of sustained VT.
METHODS: From a retrospective chart review of patients assessed between January 1990 and December 1994, 18 adult patients with VT were identified and compared with 192 with repaired TOF free of sustained arrhythmia.
RESULTS: There was no significant difference in age at repair, age at follow-up or operative history. Patients with VT had frequent ventricular ectopic beats (6 of 9 vs. 21 of 101), low cardiac index ([mean +/- SD] 2.4 +/- 0.4 vs. 3.0 +/- 0.8) and more structural abnormalities of the right ventricle (outflow tract aneurysms and pulmonary or tricuspid regurgitation) than control patients. Electrophysiologic map-guided operation was performed in 10 of 14 patients who required reoperation. VT has reoccurred in three of these patients. Four patients did not undergo operation (three received amiodarone; one underwent defibrillator implantation). Two patients with VT also had severe heart failure and died.
CONCLUSIONS: Most patients with VT late after repair of TOF have outflow tract aneurysms or pulmonary regurgitation, or both. These patients have a greater frequency of ventricular ectopic beats than arrhythmia-free patients after repair of TOF. A combined approach of correcting significant structural abnormalities (pulmonary valve replacement or right ventricular aneurysmectomy, or both) with intraoperative electrophysiologic-guided ablation may reduce the potential risk of deterioration in ventricular function and enable arrhythmia management to be optimized.

Entities:  

Mesh:

Year:  1997        PMID: 9350941     DOI: 10.1016/s0735-1097(97)00316-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  45 in total

1.  ECG predictors of ventricular arrhythmias and biventricular size and wall mass in tetralogy of Fallot with pulmonary regurgitation.

Authors:  W A Helbing; A A W Roest; R A Niezen; H W Vliegen; M G Hazekamp; J Ottenkamp; A de Roos; E E van der Wall
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

2.  Arrhythmias in Congenital Heart Disease.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

3.  An ovine model of pulmonary insufficiency and right ventricular outflow tract dilatation.

Authors:  J Daniel Robb; Matthew A Harris; Masahito Minakawa; Evelio Rodriguez; Kevin J Koomalsingh; Takashi Shuto; Yoav Dori; Robert C Gorman; Joseph H Gorman; Matthew J Gillespie
Journal:  J Heart Valve Dis       Date:  2012-03

4.  The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.

Authors:  Takuo Furukawa; Tomoaki Murakami; Michihiko Ueno; Atsuhito Takeda; Satoshi Yakuwa; Hirokuni Yamazawa
Journal:  Pediatr Cardiol       Date:  2011-09-30       Impact factor: 1.655

Review 5.  Right ventricular function late after total repair of tetralogy of Fallot.

Authors:  Alexander van Straten; Hubert W Vliegen; Mark G Hazekamp; Albert de Roos
Journal:  Eur Radiol       Date:  2005-02-22       Impact factor: 5.315

6.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

7.  Heart rate variability and exercise capacity of patients with repaired tetralogy of Fallot.

Authors:  Suchaya Silvilairat; Jatuporn Wongsathikun; Rekwan Sittiwangkul; Yupada Pongprot; Nipon Chattipakorn
Journal:  Pediatr Cardiol       Date:  2011-07-08       Impact factor: 1.655

8.  Device therapy to prevent sudden death in patients with structural heart disease.

Authors:  N Sreeram; U Trieschmann; M Emmel; M Khalil
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

9.  Signal-averaged electrocardiogram may be a beneficial prognostic procedure in the postoperative follow-up tetralogy of fallot patients to determine the risk of ventricular arrhythmias.

Authors:  Rukiye Eker Omeroglu; Seref Olgar; Kemal Nisli
Journal:  Pediatr Cardiol       Date:  2007 May-Jun       Impact factor: 1.655

10.  Cardiac arrhythmias in congenital heart diseases.

Authors:  Paul Khairy; Seshadri Balaji
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.